A proof-of-concept scale to predict asthma attacks: the OxfoRd Asthma attaCk risk ScaLE (ORACLE)
Hoofdauteurs: | Couillard, S, Laugerud, A, Jabeen, M, Ramakrishnan, S, Melhorn, J, Hinks, TSC, Pavord, ID |
---|---|
Formaat: | Conference item |
Taal: | English |
Gepubliceerd in: |
American Thoracic Society
2021
|
Gelijkaardige items
-
Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype OxfoRd Asthma attaCk risk scaLE (ORACLE)
door: Couillard Castonguay, S, et al.
Gepubliceerd in: (2022) -
Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide
door: Couillard, S, et al.
Gepubliceerd in: (2021) -
To what extent does the prototype ORACLE scale predict treatment benefits? Predicted versus observed impact of anti-inflammatory treatments
door: Couillard, S, et al.
Gepubliceerd in: (2021) -
Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids while on monoclonal antibody therapy: protocol for a prospective observational study (BOOST)
door: Howell, I, et al.
Gepubliceerd in: (2023) -
Antibiotics for asthma attacks: masking uncertainty
door: Ramakrishnan, S, et al.
Gepubliceerd in: (2021)